David Slovick was quoted in a Clinical Trials Arena article, “Cassava Sciences: Phase III Trials Storm Ahead Amid Controversy,” regarding recent charges filed by the Securities and Exchange Commission related to misleading statements made in September 2020 by Cassava Sciences.
Media Mentions
Cassava Sciences: Phase III Trials Storm Ahead Amid Controversy
October 9, 2024
New York
RELATED PEOPLE
×
Subscribe
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you're interested in learning more about.
View Subscription Center
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2024-11-14-13-11-27-495-6735f6fff42d6cc59c8ec5c1.jpg)
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2024-11-11-22-02-38-042-67327efe31216b909e6ea644.jpg)
